Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 25, 2007

View Archived Issues

Snapshots of dipeptidyl peptidase IV inhibitors from the EASD annual meeting

Survival benefit seen with picoplatin in small cell lung cancer patients

PTC-299 reduces growth of breast cancer xenografts

HE-3235 inhibits growth of MNU-induced breast tumors in rats

Recent Eisai patent reports new antipruritic agents for atopic dermatitis

Recent FibroGen patent discloses novel HIF prolyl hydroxylase inhibitors

5-HT4 receptor agonists: potential antidepressant agents with a rapid onset of action

Alba Therapeutics commences phase IIb trial of oral AT-1001 for celiac disease

NCI-sponsored trials broaden clinical development of ImClone Systems' IMC-A12

Inhibitex broadens pipeline with acquisition of FermaVir

Callisto completes patient enrollment in phase II atiprimod trial

NV1FGF angiogenesis therapy enters phase III clinical evaluation

CHDI to evaluate potential of Intellect Neuroscience's Oxigon in Huntington's disease

Wyeth discontinues development of LXR regulator

Immtech's pafuramidine granted FDA orphan drug status in African sleeping sickness

Update on Teva's edratide in systemic lupus erythematosus

Antibodies with therapeutic potential enter preclinical evaluation at Xencor

Cobiprostone tested in phase II trial for prevention of NSAID-induced ulcers in arthritis patients

Patient enrollment completed in Medicure's pivotal phase III MED-CABG II trial

FDA requires further clinical study on Alcon's Retaane suspension for wet AMD

BioCryst's peramivir does not reach primary endpoint in phase II influenza trial

Novel small molecule from Enzo protects against periodontitis-associated bone loss

CHMP issues positive opinion for Onyx and Bayer's Nexavar for HCC

Cephalon submits Treanda NDA for CLL to FDA

Merck and HVTN discontinue clinical trials of HIV vaccine V-520

Sigma 1 receptor blockade mediates the antiamnesic effects of Anavex 1-41

EC approves Pfizer's CCR5 antagonist and oral entry inhibitor Celsentri

CHMP issues positive opinion for Merck Serono's Cyanokit for cyanide poisoning

European Commission approves once-daily Exelon patch for Alzheimer's disease

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...